VATELIZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 17:41:58 GMT 2023` Edited by `admin` on `Sat Dec 16 17:41:58 GMT 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG4
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	A4R7G50030
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

VATELIZUMAB

Official Name

English

IMMUNOGLOBULIN G4, ANTI-(HUMAN .ALPHA.2.BETA.1 INTEGRIN I DOMAIN) (HUMAN-MOUSE MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL LIGHT CHAIN, DIMER

Common Name

English

GBR 500

Code

English

SAR-339658

Code

English

GBR-500

Code

English

SAR339658

Code

English

vatelizumab [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C20401

Created by admin on Sat Dec 16 17:41:58 GMT 2023 , Edited by admin on Sat Dec 16 17:41:58 GMT 2023

Code System Code Type Description

INN

9439

Created by admin on Sat Dec 16 17:41:58 GMT 2023 , Edited by admin on Sat Dec 16 17:41:58 GMT 2023

PRIMARY

CAS

1238217-55-4

Created by admin on Sat Dec 16 17:41:58 GMT 2023 , Edited by admin on Sat Dec 16 17:41:58 GMT 2023

PRIMARY

FDA UNII

A4R7G50030

Created by admin on Sat Dec 16 17:41:58 GMT 2023 , Edited by admin on Sat Dec 16 17:41:58 GMT 2023

PRIMARY

WIKIPEDIA

VATELIZUMAB

Created by admin on Sat Dec 16 17:41:58 GMT 2023 , Edited by admin on Sat Dec 16 17:41:58 GMT 2023

PRIMARY

DRUG BANK

DB12346

Created by admin on Sat Dec 16 17:41:58 GMT 2023 , Edited by admin on Sat Dec 16 17:41:58 GMT 2023

PRIMARY

NCI_THESAURUS

C152838

Created by admin on Sat Dec 16 17:41:58 GMT 2023 , Edited by admin on Sat Dec 16 17:41:58 GMT 2023

PRIMARY

ChEMBL

CHEMBL1743086

Created by admin on Sat Dec 16 17:41:58 GMT 2023 , Edited by admin on Sat Dec 16 17:41:58 GMT 2023

PRIMARY

EVMPD

SUB182700

Created by admin on Sat Dec 16 17:41:58 GMT 2023 , Edited by admin on Sat Dec 16 17:41:58 GMT 2023

PRIMARY

From	To
1_22	1_95
1_146	1_202
1_260	1_320
1_366	1_424
2_22	2_95
2_146	2_202
2_260	2_320
2_366	2_424
3_23	3_87
3_133	3_193
4_23	4_87
4_133	4_193
1_133	3_213
2_133	4_213
1_225	2_225
1_228	2_228

Glycosylation Link Type	Site
N	1_296
N	2_296

Related Record Type Details


					EZX6LLK50B

INTEGRIN ALPHA-2

TARGET -> INHIBITOR

Related Record Type Details


					A4R7G50030

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL